Niagen Bioscience (NAGE) Total Non-Current Liabilities (2011 - 2020)

Niagen Bioscience (NAGE) has 8 years of Total Non-Current Liabilities data on file, last reported at $20.2 million in Q2 2020.

• Total Non-Current Liabilities for Q2 2020 came in at $20.2 million, down 30.73% year-over-year; the trailing twelve-month figure through Jun 2020 was $20.2 million (down 30.73% YoY), and the FY2019 annual result was $19.6 million, up 32.84% from the prior year.
• Total Non-Current Liabilities rose to $20.2 million in Q2 2020 per NAGE's latest filing, from $18.8 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $29.1 million in Q2 2019 and troughed at $6.6 million in Q4 2016.
• A 5-year average of $14.0 million and a median of $13.2 million in 2016 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2019 and 2020: Total Non-Current Liabilities surged 153.45% in 2019, then slumped 30.73% in 2020.
• A 5-year view of Total Non-Current Liabilities shows it stood at $9.4 million in 2016, then dropped by 8.66% to $8.6 million in 2017, then surged by 72.33% to $14.8 million in 2018, then jumped by 32.84% to $19.6 million in 2019, then gained by 2.69% to $20.2 million in 2020.
• Business Quant data shows NAGE's Total Non-Current Liabilities at $20.2 million in Q2 2020, $18.8 million in Q1 2020, and $19.6 million in Q4 2019.